Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Merck releases first I/SPAH figures since Schering-Plough deal

Merck & Co’s 2009 full-year financial results are the first since the company sold its 50% stake in the Merial animal health business to Sanofi-Aventis in order to facilitate its merger with Schering-Plough. Although Sanofi says it is “highly probable” that it will exercise its option to merge Merial with Merck's Intervet/Schering-Plough Animal Health (I/SPAH) unit, Merck has yet to make any comment.


What to read next




Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts